Back to News
Market Impact: 0.05

Returning to the moon: An overview of the Artemis Program and Artemis II

Technology & InnovationInfrastructure & DefenseTransportation & LogisticsProduct Launches
Returning to the moon: An overview of the Artemis Program and Artemis II

NASA is preparing the Artemis II crewed lunar mission for a wet dress rehearsal on Feb. 2 with the launch window opening Feb. 6-11 (with backup windows in March and April), following the Jan. 17 rollout of the SLS and Orion to Pad 39B. The 10-day mission will carry four astronauts (Commander Reid Wiseman; Pilot Victor Glover; Mission Specialists Christina Koch and Jeremy Hansen) to validate life‑support and high‑speed return systems ahead of future lunar landings, with additional rehearsals or a rollback to the Vehicle Assembly Building possible if anomalies arise.

Analysis

Market structure: A near-term successful wet-dress and Feb 6–11 launch window de-risks revenue cadence for prime contractors — Lockheed Martin (LMT), Northrop Grumman (NOC) and Boeing (BA) are direct beneficiaries via contract cashflow and follow-on sustainment work. Pricing power is limited: SLS is government-funded and largely cost-plus/fixed‑contract, so upside to margins is muted while revenue visibility improves; aerospace suppliers (composites, avionics) will see volume spikes but concentrated supplier risk. Cross-asset: positive shock to A&D equities and selective industrials, small effects on Treasuries (modest duration/flight-to-quality moves on mission failure), and short-term spikes in single-stock options IV for primes and key suppliers ahead of milestones. Risk assessment: Tail risks include a launch failure or rollback (VEHICLE ASSEMBLY BUILDING rework) that could trigger 8–20% negative re-rating in exposed primes within days and political budget scrutiny over 3–12 months. Immediate catalyst windows are wet-dress (Feb 2) and launch window (Feb 6–11); a slip into March/April or announced rollback is a high-confidence negative signal. Hidden dependencies: single-source suppliers for SRBs, avionics or heat-shield components; second-order effects include accelerated use of commercial alternatives (SpaceX) if SLS cost/time overruns persist. Trade implications: Tactical—establish 1.5–3% long positions split LMT (1.0%) and NOC (0.8%) before Feb 2 to capture de-risking; pair trade long LMT + NOC, short BA 1:1 sized (size 1–1.5%) to hedge Boeing execution risk, cut if NASA announces rollback or delay to March. Options—buy 3‑month call spreads (10–20% OTM) on LMT/NOC sized to 0.5–1% portfolio to lever upside while capping premium; buy 2–3% exposure to aerospace ETF ITA to play sector re-rating but limit to underweight financials. Exit/trim if delays extend beyond March 31 or if stock moves >+20% post-launch. Contrarian angles: Consensus prizes primes; market under-appreciates that a single successful Artemis II may accelerate commercial lunar competition (SpaceX) and shift long-term funding away from SLS — primes’ long-term cashflows are not guaranteed. Look for mispricings in mid/small-cap suppliers (e.g., MAXR-sized space infrastructure contractors) that could be acquisition targets after a successful mission; conversely, an Artemis failure would likely produce knee-jerk 10–20% selloffs and create buying windows for high-quality defense names over 6–12 months based on budgetary stimulus restoring demand.